After determining the biological variance based on our measured proteins within the whole cohort, we correlated PC levels with Alzheimer’s disease biomarkers, cognitive test scores, and laboratory markers taking into account clinical groups and ATN status. This evidence concerns the gene TYR and Alzheimer disease.